Stay updated on Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Sign up to get notified when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.

Latest updates to the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page
- Check7 days agoChange DetectedThe revision indicator on the page updated from v3.6.4 to v3.6.5, signaling a new deployment of the site’s interface. This change does not modify study details or eligibility information.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision badge updated from v3.6.3 to v3.6.4, indicating a site version update. No study details, eligibility criteria, or results are changed by this update.SummaryDifference0.1%

- Check29 days agoNo Change Detected
- Check43 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a minor update to the listing. This change does not alter the trial details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, indicating a newer release of the page. No changes to the study details or content are introduced.SummaryDifference0.1%

- Check64 days agoChange DetectedRecruitment has ended on this study page ('No longer looking for participants'), and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) to improve navigation. The Intervention/Treatment header formatting was adjusted, the old 'Intervention / Treatment' header removed, and the revision label updated from v3.5.5 to v3.6.0.SummaryDifference0.5%

- Check72 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a minor page or CMS update. This change does not modify the study details, enrollment information, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Ibrutinib Combo in Recurrent HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ibrutinib Combo in Recurrent HNSCC Clinical Trial page.